Addex management commentary: H1 2026 net loss holds near CHF 3.5 million as Neurosterix share-of-loss offsets lower R&D spend
Bitget2026/09/28 11:07- Addex management commentary on the six months ended June 30, 2026 flagged continued losses, with net loss from continuing operations of CHF 3.46 million.
- Operating loss narrowed to CHF 1.13 million as research and development costs fell to CHF 74,000, reflecting no self-funded clinical studies.
- General and administrative costs were steady at CHF 1.07 million, with higher staff costs partly offset by lower professional fees.
- Results were weighed down by CHF 2.33 million share of loss from its 20% equity-method investment in Neurosterix.
- Liquidity remained tight, with CHF 0.8 million cash at June 30, 2026; management cited USD 2.8 million raised post-period via share sales.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The British Pound rallies on a UK growth upgrade and gives more than half back
Only twice in history! S&P 500 equal-weight index is expected to record seven consecutive weeks of decline this week
The S&P 500 Equal Weight Index is expected to fall for a seventh consecutive week. If this downward trend continues through Friday, it will mark only the third time in history that the index has experienced seven straight weeks of decline.
Trump “bites” Powell, demanding his resignation from the Federal Reserve Board, citing severe cost overruns in headquarters renovation.
U.S. President Trump on Wednesday called for former Federal Reserve Chairman Powell to resign from his position as a Fed governor, following an inspector general report on the Federal Reserve headquarters renovation project, which highlighted a series of management issues that led to significant cost overruns.
Crypto prices
More
